A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried

Summary

The Phase 1 clinical trial of the freeze-dried human rabies vaccine (human diploid cells) will be conducted on participants aged 10 to 60. This study will design a single-arm, randomized, open-access trial with different immunization schedules (5-dose schedule and 2-1-1 schedule) to evaluate the safety and tolerability of the vaccine in participants aged 10 to 60

Timeline

Start

2025-05-23

Primary completion

2025-07-28

Completion

2025-12-31

Drugs

Indications